Azetidinimines as carbapenemases inhibitors
US11174226B2 · kind B2 · utility
0Cited by
0References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2016 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Sep 7, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to novel azetidinimine of formula (I). Wherein R1-R6 are as defined in claim 1. The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates to their use in antibiotic therapies and their methods of synthesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.